PYC Therapeutics Limited Share Price
Stocks
PYC
AU000000PYC7
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.140 AUD | +2.39% |
|
+17.58% | +29.31% |
| 07/08 | ASX Biggest Losers | MT |
| 04/08 | ASX Biggest Gainers | MT |
| Market Cap | 210.47Cr 148.6Cr 128.77Cr 120.55Cr 110Cr 206.99Cr 14TCr 1.41TCr 553.83Cr 7.09TCr 557.93Cr 545.78Cr 24TCr | P/E 2026 * |
-29.6x | P/E 2027 * | -23.2x |
|---|---|---|---|---|---|
| Enterprise Value | 144.04Cr 101.7Cr 88Cr 83Cr 75Cr 141.66Cr 9.7TCr 967.42Cr 379.04Cr 4.86TCr 381.85Cr 373.53Cr 16TCr | EV / Sales 2026 * |
393x | EV / Sales 2027 * | - |
| Free-Float |
70.64% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: PYC Therapeutics Limited
| 17/03 | Bell Potter rates PYC as Speculative Buy | AQ |
| 09/25/09 | Bell Potter rates PYC as Speculative Buy | AQ |
| 07/24/07 | PYC Therapeutics : Anti Bribery & Anti Corruption Policy | PU |
| 07/24/07 | PYC Therapeutics : Definition of Independence | PU |
| 07/24/07 | PYC Therapeutics : Continuous Disclosure Policy | PU |
| 1 day | +2.39% | ||
| 1 week | +17.58% | ||
| Current month | +25.88% | ||
| 1 month | +37.62% | ||
| 3 months | +73.98% | ||
| 6 months | +44.59% | ||
| Current year | +29.31% |
| 1 week | 1.98 |  | 2.18 |
| 1 month | 1.52 | | 2.18 |
| Current year | 1.04 | | 2.18 |
| 1 year | 0.85 | | 2.18 |
| 3 years | 0.52 | | 2.18 |
| 5 years | 0.5 | | 2.18 |
| 10 years | 0.14 | | 2.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rohan Hockings
CEO | Chief Executive Officer | 42 | 19/08/2020 |
Thomas Ulmer
DFI | Director of Finance/CFO | 47 | 07/07/2026 |
Sri Mudumba
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Rohan Hockings
BRD | Director/Board Member | 42 | 30/11/2018 |
Ian Constable
BRD | Director/Board Member | - | 22/09/2025 |
Peter Coleman
CHM | Chairman | 66 | 18/11/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23/12/25 | Free | Chairman | 20,00,000 | 0.3429% | ||
| 26/11/25 | Buy | Chief Executive Officer | 1,33,350 | 0.0229% | ||
| 27/02/25 | Australia Land Pty Ltd.
| Buy | Company | 2,80,00,000 | 6.0008% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.39% | +17.58% | +61.51% | +289.09% | 145.23Cr | |
| -0.72% | +3.41% | +6.32% | +16.27% | 5TCr | |
| -0.97% | +5.99% | +490.92% | +583.73% | 4.44TCr | |
| +0.40% | +11.81% | +24.65% | +82.70% | 4.08TCr | |
| +1.15% | +7.35% | +36.03% | +11.43% | 3.98TCr | |
| +4.73% | +15.53% | +26.95% | +54.62% | 3.25TCr | |
| -0.64% | +4.01% | - | - | 1.69TCr | |
| +0.74% | +5.58% | +35.00% | +127.50% | 1.68TCr | |
| -0.20% | +1.57% | +5.49% | +21.35% | 1.4TCr | |
| +1.33% | +20.11% | +88.81% | +31.12% | 1.32TCr | |
| Average | +0.83% | +252.18% | +86.19% | +135.31% | 2.7TCr | |
| Weighted average by Cap. | +0.60% | +293.74% | +108.03% | +140.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 36.67L 25.89L 22.43L 21L 19.16L 36.06L 25Cr 2.46Cr 96.48L 12Cr 97.2L 95.08L 41Cr | - |
| Net income | -5.74Cr -4.05Cr -3.51Cr -3.29Cr -3Cr -5.65Cr -386.74Cr -39Cr -15Cr -193.57Cr -15Cr -15Cr -645.8Cr | -8.58Cr -6.05Cr -5.25Cr -4.91Cr -4.48Cr -8.43Cr -577.43Cr -58Cr -23Cr -289.02Cr -23Cr -22Cr -964.22Cr |
| Net Debt | -66Cr -47Cr -41Cr -38Cr -35Cr -65Cr -4.47TCr -446.13Cr -174.79Cr -2.24TCr -176.09Cr -172.25Cr -7.47TCr | -58Cr -41Cr -35Cr -33Cr -30Cr -57Cr -3.9TCr -388.7Cr -152.3Cr -1.95TCr -153.42Cr -150.08Cr -6.51TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | A$2.140 | +2.39% | 22,23,443 |
| 10/26/10 | A$2.090 | +2.45% | 11,74,447 |
| 07/26/07 | A$2.040 | -4.23% | 14,10,956 |
| 06/26/06 | A$2.130 | +1.43% | 33,60,149 |
| 05/26/05 | A$2.100 | +5.26% | 33,23,845 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PYC Stock
Select your edition
All financial news and data tailored to specific country editions
